Drug Discovery: Wednesday, April 18, 2012

BioPharma: Tuesday, April 17, 2012 ›

Pharma Trials: Wednesday, April 18, 2012 ›

Generics Congress: Wednesday, April 18, 2012 ›

Drug Discovery: Wednesday, April 18, 2012 ›

last modified: 03 April '12

Please enable javascript to see more information on speakers

Supporting original drug discovery

8.50am

Chairman's opening remarks

Dr. Ajay Gautam

Dr. Ajay Gautam is Executive Director and Head of Emerging Markets Collaborations for AstraZeneca where he is leading the development and implementation of AstraZeneca R&D’s strategy and collaborations in Emerging Markets. Prior to joining...

more..

› Dr. Ajay Gautam, Executive Director, Head, Emerging Markets Collaborations, AstraZeneca

9am

Innovation in biotech partnerships: from academics to IPOs

Fernando Kreutz at BioPharma LatAm Convention

› Fernando Kreutz, President, FK Biotec

9.30am

Pfizer External R&D Innovation (ERDI): a vehicle to leverage innovative external science in Latin America

Gabriela Cezar at BioPharma LatAm Convention

› Gabriela Cezar, Senior Director & Head – Brazil, External R&D Innovation, Pfizer Inc.

10am

Open innovation: Generating value from strategic partnerships and alliances

Marcio de Paula

Marcio de Paula is veterinarian with extensive experience on drug discovery/development, R&D project and strategic alliances/partnerships management. He currently holds the Strategy Management Officer position at Biolab Pharma.

more..

› Marcio de Paula, Strategy Management Officer, Biolab Sanus Farma

10.30am

Networking coffee break

Drug development landscape

11am

Local support for drug development: Brazil's pre-clinical drug institute

Joao Calixto

João B. Calixto received degree in Biological Sciences in 1973 at the University of Brasilia and then concluded his Master Science in Pharmacology by Federal University of São Paulo, (EPM) in 1976 and this PhD in Pharmacology in 2004, at the...

more..

› Joao Calixto, Departamento de Farmacologia, Universidade Federal de Santa Catarina

11.25am

Plant derived alkaloid (-)-cassine induces anti-inflammatory and anti-hyperalgesics effects in both acute and chronic inflammatory and neuropathic pain models

Cristiano Funari

Possui graduação em Engenharia Química pela Universidade Estadual de Campinas (1999), tendo obtido o grau de mestre em Fármaco e Medicamentos (Farmacognosia) pela Universidade de São Paulo - USP (2005) e doutorado em Química (Produtos Naturais) pelo ...

more..

› Cristiano Funari, Professor, Chemistry Institute, UNESP

11.50am

Development of in-vitro tissue-engineered cartilage

Ronaldo Amaral

Ronaldo graduated in Biology (Genetics) in Federal University of Rio de Janeiro in 2009. Nowadays he is a PhD student from the Morphological Sciences Program of the Biomedical Sciences Institute at the same university, where he also achieved a...

more..

› Ronaldo Amaral, Laboratório de Proliferação e Diferenciação Celular, Universidade Federal do Rio de Janeiro

12.15pm

Medicinal chemistry for drug discovery: challenges and opportunities

Dr. Adriano Andricopulo at BioPharma LatAm Convention

› Dr. Adriano Andricopulo, Professor, University of Sao Paulo - Brazil

12.40pm

Networking lunch

1.40pm

Ethical issues related to the access to orphan drugs in Brazil: the case of mucopolysaccharidosis type I

Raquel Boy at BioPharma LatAm Convention

› Raquel Boy, Professor of Pediatrics, State University of Rio de Janeiro

2.10pm

Cadaveric bone marrow mesenchymal stem cells for the treatment of large burns: first worldwide clinical trial

Dr Eduardo Raul Mansilla at BioPharma LatAm Convention

› Dr Eduardo Raul Mansilla, Professor of Internal Medicine National University of La Plata, Argentina
Director of the Regenerative Medicine, Tissue Engineering and Cell Therapies Laboratory, CUCAIBA , Province of Buenos Aires, Ministry of Health, Argentina

2.40pm

Networking coffee break

3.10pm

Laboratory routes to generic drugs: the use of homogeneous and heterogeneous catalysis

Carlos Correia

Carlos Roque Duarte Correia received his Bachelor’s degree in Pharmacy from the Federal University of Rio de Janeiro (UFRJ) in 1976 followed by a Master’s degree in Chemistry of Natural Products in 1980. In 1981 he was accepted at the graduate...

more..

› Carlos Correia, Professor, Campinas State University

3.40pm

Molecular assay optimized by Taguchi experimental design method for venous thromboembolism investigation

Helder Souza at BioPharma LatAm Convention

› Helder Souza, Healthcare Solutions & Project Manager - LATAM, Siemens Healthcare Diagnostics

4.10pm

Isoniazid metal complex reactivity and insights for a novel anti-tuberculosis drug design

Eduardo Sousa

Dr Sousa earned his bachelor degree in Chemistry (1998), Masters(2000) and Doctoral in Chemistry (2003) at the Federal University of Ceará(Brazil) working with bioinorganic chemistry. In 2001, he spent time doing research at the San Francisco State...

more..

› Eduardo Sousa, Professor, Federal University of Ceará

Products in the market

4.40pm

Case study: Successful drug development in Latin America

Samuel Silva

Samuel Silva, PhD has several years of experience in the pharmaceutical research and development field. Dr. Silva Currently heads the R&D operations at Cristalia Quimica & Farmaceutica in Sao Paulo, Brazil, in this position he is responsible for...

more..